Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA, Made in India, NDC 0378-1075-93. Recall

Ongoing
Drugs
Class III — Low Risk

Recall Date

Oct 28, 2026

Company

Viatris, Inc.

Source

FDA

Units

21,620 30-count bottles

Reason: Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications

Class III: Use of the product is unlikely to cause health problems, but violates FDA regulations.

Official FDA recall notice

Information is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.

Recall Details

Description

Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications

Reason for Recall

Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications

Product: Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA, Made in India, NDC 0378-1075-93.
Official Recall ID: FDA-DRUG-D-0049-2027
Units affected: 21,620 30-count bottles

What Should I Do?

Check your lot number. Don't stop taking a prescribed medication without talking to your pharmacist or doctor. Contact the pharmacy where you got it about a replacement.

Quantity: 21,620 30-count bottles

Remediation GuideAction Required

5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.

1
Confirm Your Product Is Affected
2
Read the Full Recall Notice
3
Stop Using the Product if in Doubt

+2 more steps…

View Official Recall Notice (FDA)

Last updated November 3, 2026

Injured by a recalled product?

Our legal partners offer free consultations for recall victims.

Get Free Legal Help →Sponsored

Stay Informed

Weekly recall digest — free, no spam.